Capricor Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, presented an abstract entitled "ALLogeneic Heart STem Cells To Achieve Myocardial Regeneration : The Six Month Phase I Safety Results" with an oral presentation by Dr. Raj R. Makker of Cedars-Sinai Medical Center, at the Transcatheter Cardiovascular Therapeutics conference at the Walter E. Washington Convention Center, Washington, DC, on September 16, 2014.
http://ift.tt/Xood5A
http://ift.tt/Xood5A
No comments:
Post a Comment